Nexus Pharmaceuticals to Build Industry-Leading Sterile Injectable Manufacturing Facility in Pleasant Prairie, Wisconsin Read more
Sanofi : FDA to review isatuximab as a potential treatment for relapsed/refractory multiple myeloma Read more
Schreiner MediPharm Introduces Multi-Tear Closure Label for Double Tamper Protection in Pharmaceutical Packaging Read more
Ligand Announces Positive Top Line Results from Phase 1 Clinical Trial of Captisol-enabled Iohexol Read more
Celsius Therapeutics Signs Collaboration Agreement with Janssen to Identify Response Biomarkers for Ulcerative Colitis Read more
MacroGenics and I-Mab Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Enoblituzumab in Greater China Read more
ReachBio Research Labs Offers New Services for ADC Off-target Toxicity and Linker Stability Read more